Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer

Psycho-Oncology

Volumn 18, Issue 3, 2009, Pages 237-247

  Cherrier, M M ^a,b   Aubin, S ^a   Higano, C S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Cognition; Compete androgen blockade (CAB); Flutamide; Intermittent androgen deprivation therapy (ADT); Memory; Mood; Prostate cancer; Testerone

Indexed keywords

ANTIANDROGEN; FLUTAMIDE; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ANDROGEN DEPRIVATION THERAPY; ANXIETY; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; EDUCATION; FATIGUE; FOLLOW UP; HUMAN; IRRITABILITY; LANGUAGE; MALE; MENTAL STRESS; METASTASIS; MOOD CHANGE; PROSTATE CANCER; SELECTIVE ATTENTION; SELF REPORT; SIDE EFFECT; SPATIAL MEMORY; VERBAL MEMORY; WORKING MEMORY; ATTITUDE TO HEALTH; BLOOD; COGNITIVE DEFECT; DEPTH PERCEPTION; HOSPITALIZATION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ANDROGEN ANTAGONISTS; ATTITUDE TO HEALTH; COGNITION DISORDERS; DEPRESSION; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPACE PERCEPTION;

EID: 67349254217     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1401     Document Type: Article

References (79)

1. American Cancer Society. Overview: Prostate Cancer, 2008. Available: http://www.cancer.org/docroot/CRI/content/ CRI_2_2_1X_How_many_n_prostateňcer_36.asp?sitearea=. Assessed 28 March 2008.
2. Higano C. Androgen deprivation therapy: monitoring and managing the complications. Hematol Oncol Clin North Am 2006;20:909-923.
3. Holmes L, Jr., Chan W, Jiang Z, Du XL. Effectiveness of androgen deprivation therapy in prolonging survival of older men treated for locoregional prostate cancer. Prostate Cancer Prostatic Dis 2007;10(4):95.
4. Ramirez ML, Keane TE, Evans CP. Managing prostate cancer: the role of hormone therapy. Can J Urol 2007;14(Suppl 1):10-18.
5. Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, Sullivan LD. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer 1993;71:2782-2790.
6. Sato N, Gleave ME, Bruchovsky N et al. Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model. J Steroid Biochem Mol Biol 1996;58:139-146.
7. Stoch SA, Parker RA, Chen L et al. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 2001;86:2787-2791.
8. Higano C, Shields A, Wood N, Brown J, Tangen C. Bone mineral density in patients with prostate cancer without bone metastases treated with intermittent androgen suppression. Urology 2004; 64:1182-1186.
9. Keating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006;24: 4448-4456.
10. Joly F, Alibhai SM, Galica J et al. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol 2006; 176:2443-2447.
11. Kato T, Komiya A, Suzuki H, Imamoto T, Ueda T, Ichikawa T. Effect of androgen deprivation therapy on quality of life in Japanese men with prostate cancer. Int J Urol 2007;14:416-421.
12. Shapiro PJ, Coyne JC, Kruus LK, Palmer SC, Vaughn DJ, Malkowicz SB. Interest in services among prostate cancer patients receiving androgen deprivation therapy. Psycho-Oncology 2004;13:512-525.
13. Herr HW, Kornblith AB, Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 1993;71:1143-1150.
14. Herr HW, O'Sullivan M. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol 2000;163:1743-1746.
15. Salminen E, Portin R, Korpela J et al. Androgen deprivation and cognition in prostate cancer. Br J Cancer 2003;89:971-976.
16. Jenkins VA, Bloomfield DJ, Shilling VM, Edginton TL. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU Int 2005;96:48-53.
17. Lamb DS, Denham JW, Mameghan H et al. Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer. Radiother Oncol 2003;68:255-267.
18. Kritzer MF, Brewer A, Montalmant F, Davenport M, Robinson JK. Effects of gonadectomy on performance in operant tasks measuring prefrontal cortical function in adult male rats. Horm Behav 2007; 51:183-194.
19. Hajszan T, MacLusky NJ, Johansen JA, Jordan CL, Leranth C. Effects of androgens and estradiol on spine synapse formation in the prefrontal cortex of normal and testicular feminization mutant male rats. Endocrinology 2007;148:1963-1967.
20. Frye CA, Seliga AM. Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats. Cogn Affect Behav Neurosci 2001;1:371-381.
21. Naghdi N, Oryan S, Etemadi R. The study of spatial memory in adult male rats with injection of testosterone enanthate and flutamide into the basolateral nucleus of the amygdala in Morris water maze. Brain Res 2003;972:1-8.
22. Cherrier MM. Androgens and cognitive function. J Endocrinol Invest 2005;28:65-75.
23. Barrett-Connor E, Goodman-Gruen D, Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab 1999; 84:3681-3685.
24. Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 2002;87:5001-5007.
25. Janowsky JS, Oviatt SK, Orwoll ES. Testosterone influences spatial cognition in older men. Behav Neurosci 1994;108:325-332.
26. Beer TM, Bland LB, Bussiere JR et al. Testosterone loss and estradiol administration modify memory in men. J Urol 2006; 175:130-135.
27. Green HJ, Pakenham KI, Gardiner RA. Effects of lutenizing hormone releasing hormone analogs on cognition in women and men: A review. Psychol, Health Med 2000;5:407-418.
28. Cherrier MM, Rose AL, Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol 2003;170:1808-1811.
29. Salminen EK, Portin RI, Koskinen A, Helenius H, Nurmi M. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res 2004;10:7575-7582.
30. Almeida OP, Waterreus A, Spry N, Flicker L, Martins RN. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 2004;29:1071-1081.
31. Falleti MG, Maruff P, Collie A, Darby DG. Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals. J Clin Exp Neuropsychol 2006;28:1095-1112.
32. Tiernan K, Schenk K, Shimonova M et al. An examination of the validity and reliability of a novel route test in healthy older adults and AD Patients. Clin Neuropsychol 2004;8:39-42.
33. Cherrier MM, Asthana S, Baker LD et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 2001;57:80-88.
34. Cherrier MM, Matsumoto AM, Amory JK et al. Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men. Psychoneuroendocrinology 2007;32:72-79.
35. Wechsler D. Weschler Adult Intelligence Scale - Revised. The Psychological Corporation: San Antonio, TX, 1981.
36. O'Connor DB, Archer J, Hair WM, Wu FC. Activational effects of testosterone on cognitive function in men. Neuropsychologia 2001;39:1385-1394.
37. Wechsler D. WAIS-III Administration and Scoring Manual. The Psychological Corporation: San Antonio, TX, 1997.
38. Vandenberg SG, Kuse AR. Mental rotations, a group test of three-dimensional spatial visualization. Percept Mot Skills 1978;47:599-601.
39. Kimura D. Sex and Cognition. The MIT Press: Cambridge, MA, 1999.
40. Silverman I, Kastuk D, Choi J, Phillips K. Testosterone levels and spatial ability in men. Psychoneuroendocrinology 1999; 24:813-822.
41. Hooven CK, Chabris CF, Ellison PT, Kosslyn SM. The relationship of male testosterone to components of mental rotation. Neuropsychologia 2004;42:782-790.
42. Schoning S, Engelien A, Kugel H et al. Functional anatomy of visuo-spatial working memory during mental rotation is influenced by sex, menstrual cycle, and sex steroid hormones. Neuropsychologia 2007.
43. Sommer IE, Cohen-Kettenis PT, van Raalten T et al. Effects of cross-sex hormones on cerebral activation during language and mental rotation: an fMRI study in transsexuals. Eur Neuropsychopharmacol 2008;18:215-221.
44. Shepard RN, Metzler J. Mental rotation of three-dimensional objects. Science 1971;171:701-703.
45. Shepard S, Metzler D. Mental rotation: effects of dimensionality of objects and type of task. J Exp Psychol Hum Percept Perform 1988;14:3-11.
46. Moscovitch M. Cognitive resources and dual-task interference effects on retrieval in normal people: the role of the frontal lobes and medial temporal cortex. Neuropsychology 1994;8:524-534.
47. Shimamura AP, Jurica PJ, Mangels JA, Gershberg FB. Susceptibility to memory interference effects following frontal lobe damage: findings from tests of paired-associate learning. J Cogn Neurosci 1995; 7:144-152.
48. Loewenstein DA, Acevedo A, Agron J, Duara R. Vulnerability to proactive semantic interference and progression to dementia among older adults with mild cognitive impairment. Dement Geriatr Cogn Disord 2007; 24:363-368.
49. Postle BR, Brush LN, Nick AM. Prefrontal cortex and the mediation of proactive interference in working memory. Cogn Affect Behav Neurosci 2004;4:600-608.
50. Jonides J, Nee DE. Brain mechanisms of proactive interference in working memory. Neuroscience 2006; 139:181-193.
51. McDonald CR, Bauer RM, Grande L, Gilmore R, Roper S. The role of the frontal lobes in memory: evidence from unilateral frontal resections for relief of intractable epilepsy. Arch Clin Neuropsychol 2001; 16: 571-585.
52. Jacoby LL, Debner JA, Hay JF. Proactive interference, accessibility bias, and process dissociations: valid subjective reports of memory. J Exp Psychol Learn Mem Cogn 2001;27:686-700.
53. Wechsler D. Wechsler Memory Scale - Revised. The Psychological Corporation: San Antonio, TX, 1987.
54. Craft S, Asthana S, Newcomer JW et al. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry 1999;56:1135-1140.
55. Craft S, Dagogo-Jack E, Wiethop CM et al. The effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer's type: a longitudinal study. Behav Neurosci 1993; 107:926-941.
56. Craft S, Murphy C, Wemstrom J. Glucose effects on memory and complex non-memory measures: the in.uence of age, sex, and glucoregulatory response. Psychobiology 1994;22:95-105.
57. Craft S, Zallen G, Baker LD. Glucose and memory in mild senile dementia of the Alzheimer type. J Clin Exp Neuropsychol 1992; 14:253-267.
58. Wolf OT, Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav 2002; 41:259-266.
59. Spreen O, Strauss E. A Compendium of Neuropsychological Tests. Oxford University Press: New York, 1991.
60. Lezak MD. Neuropsychologcial Assessment (3rd edn.). Oxford University Press: New York, NY, 1995.
61. Glueck CJ, Glueck HI, Stroop D, Speirs J, Hamer T, Tracy T. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men. J Lab Clin Med 1993;122:412-420.
62. Petrides M, Milner B. Deficits on subject-ordered tasks after frontal and temporal lobe lesions in man. Neuropsychologia 1982; 20:249-262.
63. Bryan J, Luszcz MA. Adult age differences in Self-Ordered Pointing Task performance: contributions from working memory, executive function and speed of information processing. J Clin Exp Neuropsychol 2001; 23:608-619.
64. Daigneault S, Braun CM. Working memory and the Self-Ordered Pointing Task: further evidence of early prefrontal decline in normal aging. J Clin Exp Neuropsychol 1993;15:881-895.
65. McNair DM, Lorr M, Droppleman LF. Profile of Mood States. Educational and Industrial Testing Service: San Diego, CA, 1981.
66. Steiner M, Streiner DL. Validation of a revised visual analog scale for premenstrual mood symptoms: results from prospective and retrospective trials. Can J Psychiatry 2005;50:327-332.
67. Pearlstein TB, Halbreich U, Batzar ED et al. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry 2000;61:101-109.
68. Huber A, Suman AL, Rendo CA, Biasi G, Marcolongo R, Carli G. Dimensions of "unidimensional" ratings of pain and emotions in patients with chronic musculoskeletal pain. Pain 2007;130:216-224.
69. Di Benedetto M, Lindner H, Hare DL, Kent S. A Cardiac Depression Visual Analogue Scale for the brief and rapid assessment of depression following acute coronary syndromes. J Psychosom Res 2005; 59:223-229.
70. Driscoll I, Hamilton DA, Yeo RA, Brooks WM, Sutherland RJ. Virtual navigation in humans: the impact of age, sex, and hormones on place learning. Horm Behav 2005;47:326-335.
71. McKeever WF, Rich DA, Deyo RA, Conner RL. Androgens and spatial ability: failure to find a relationship between testosterone and ability measures. Bull Psychonomic Soc 1987;25:438-440.
72. Moffat SD, Hampson E. A curvilinear relationship between testosterone and spatial cognition in humans: possible influence of hand preference. Psychoneuroendocrinology 1996;21:323-337.
73. Hampson E, Moffat SD. Is testosterone related to spatial cognition and hand preference in humans? Brain Cogn 1994;26:255-266.
74. Green HJ, Pakenham KI, Headley BC et al.Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int 2002;90:427-432.
75. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 2005;59:60-70.
76. Taxel P, Stevens MC, Trahiotis M, Zimmerman J, Kaplan RF. The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer. J Am Geriatr Soc 2004;52:269-273.
77. Pirl WF, Siegel GI, Goode MJ, Smith MR. Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study. Psycho-Oncology 2002; 11:518-523.
78. Edinger KL, Frye CA. Androgens' performance-enhancing effects in the inhibitory avoidance and water maze tasks may involve actions at intracellular androgen receptors in the dorsal hippocampus. Neurobiol Learn Mem 2007;87:201-208.
79. Gillatt D. Antiandrogen treatments in locally advanced prostate cancer: are they all the same? J Cancer Res Clin Oncol 2006; 132(Suppl 1):S17-26.